Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kornberg

Showing results (901-910 of 1,008) with videos related to

Pageof 101
Sort By:
Journal of Medicinal Chemistry|January 1, 1992
Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitorsA M Doherty, I Sircar, B E Kornberg, et al.
Journal of Medicinal Chemistry|June 1, 1990
Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensivesJ J Mencel, J R Regan, J Barton, et al.
Molecular Cell|February 11, 2021
Mediator structure and conformation changeHeqiao Zhang, Dong-Hua Chen, Rayees U H Mattoo, et al.
Applied Optics|November 13, 2008
Metal mesh resonant filters for terahertz frequenciesArline M Melo, Mariano A Kornberg, Pierre Kaufmann, et al.
American Journal of Medical Genetics. Part A|March 10, 2023
A cryptic pathogenic NDUFV1 variant identified by RNA-seq in a patient with normal complex I activity in muscle and transient magnetic resonance imaging changesSharmila Kiss, John Christodoulou, David R Thorburn, et al.
Investigational New Drugs|July 7, 2012
Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokineticsNwabundo Nwankwo, Zhe Zhang, Ting Wang, et al.
Science (New York, N.Y.)|April 28, 2000
Architecture of RNA polymerase II and implications for the transcription mechanismP Cramer, D A Bushnell, J Fu, et al.
Neuromuscular Disorders : NMD|September 11, 2002
CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin lociR M I Kapsa, S H A Wong, I Bertoncello, et al.
Neurology|March 20, 2013
International Pediatric MS Study Group Clinical Trials Summit: meeting reportTanuja Chitnis, Marc Tardieu, Maria Pia Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2013
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitionsLauren B Krupp, Marc Tardieu, Maria Pia Amato, et al.
Pageof 101

Showing results (901-910 of 1,008) with videos related to

Sort By:
Pageof 101
Journal of Medicinal Chemistry|January 1, 1992
Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitorsA M Doherty, I Sircar, B E Kornberg, et al.
Journal of Medicinal Chemistry|June 1, 1990
Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensivesJ J Mencel, J R Regan, J Barton, et al.
Molecular Cell|February 11, 2021
Mediator structure and conformation changeHeqiao Zhang, Dong-Hua Chen, Rayees U H Mattoo, et al.
Applied Optics|November 13, 2008
Metal mesh resonant filters for terahertz frequenciesArline M Melo, Mariano A Kornberg, Pierre Kaufmann, et al.
American Journal of Medical Genetics. Part A|March 10, 2023
A cryptic pathogenic NDUFV1 variant identified by RNA-seq in a patient with normal complex I activity in muscle and transient magnetic resonance imaging changesSharmila Kiss, John Christodoulou, David R Thorburn, et al.
Investigational New Drugs|July 7, 2012
Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokineticsNwabundo Nwankwo, Zhe Zhang, Ting Wang, et al.
Science (New York, N.Y.)|April 28, 2000
Architecture of RNA polymerase II and implications for the transcription mechanismP Cramer, D A Bushnell, J Fu, et al.
Neuromuscular Disorders : NMD|September 11, 2002
CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin lociR M I Kapsa, S H A Wong, I Bertoncello, et al.
Neurology|March 20, 2013
International Pediatric MS Study Group Clinical Trials Summit: meeting reportTanuja Chitnis, Marc Tardieu, Maria Pia Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2013
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitionsLauren B Krupp, Marc Tardieu, Maria Pia Amato, et al.
Pageof 101